Heiddis B Valdimarsdottir, PhD Email Heiddis Valdimarsdottir
- ASSOCIATE PROFESSOR | Population Health Science and Policy
- ASSOCIATE PROFESSOR | Oncological Sciences
Dr. Heiðdís Valdimarsdóttir has extensive experience in the psychological and biological evaluation of individuals with cancer and among individuals at familial/genetic risk for breast cancer, and has conducted numerous R01 awards, including studies focused on: biological correlates of distress and psychobiological reactivity to acute stressors and among individuals at risk for cancer, developing and testing culturally targeted genetic counseling interventions for minority women to help them with their BRCA testing decisions, developing and testing interactive CDROM decision task to help BRCA mutation carriers with the preventive and surveillance decisions, examining the impact of expressive writing intervention in reducing psychological and biological indices of stress among cancer patients, and developed and pilot tested and intervention examining if exposure to circadian-effective affects circadian rhythms, fatigue, depression and sleep among cancer patients and cancer survivors. Internationally, Dr. Valdimarsdóttir collaborates with Dr. Robert Zachariae at the University of Aarhus, Denmark, Dr. Eveline Bleiker at the Netherlands Cancer Institute and Dr. Birna Baldursdóttir at the Reykjavík University Iceland.
Behavioral Health, Breast Cancer, Cancer, Cancer Genetics, Chronic Fatigue Syndrome, Depression, Hematopoiesis, Immunology, Prostate, Psychiatry
Bachelors of Arts (BA), University of Iceland
Doctorate of Psychology (PhD), S.U.N.Y. at Stony Brook
Postdoctoral Research Associate, S.U.N.Y. at Stony Brook
Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center
Psychological, Behavioral, And Biological Consequences Of Being At Familial Risk For Cancer
Heiddis Valdimarsdottir, Ph.D.'s current research investigates the psychological, behavioral, and biological consequences of being at familial risk for cancer, including investigating the psychosocial issues surrounding genetic testing for cancer susceptibility. Current research includes studies on testing interventions for reducing distress and increasing participants' understanding of the implications of testing among African American women, as well as investigating psychosocial factors involved in seeking genetic testing and the consequences of testing among Ashkenazi Jewish women.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Valdimarsdottir has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.